Atlas Trials

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)

Clinical trial NCT04315896 · COMPLETED

Trial details

NCT number
NCT04315896
Sponsor
National Institute of Respiratory Diseases, Mexico
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19Severe Acute Respiratory Syndrome
Start date
2020-04-14
Primary completion
2020-07-01
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.